MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1).Continue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Starting in November, the United States plans to lift travel restrictions on people coming from overseas who are fully vaccinated against COVID-19. This move by the Biden administration will open the United States to relatives separated from families as well as business travelers.Continue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Pregnant women infected with certain strains of human papillomavirus (HPV) may have a heightened risk of preterm birth, a new study suggests. HPV is a sexually transmitted disease that can cause genital warts. Most of the time, the immune system clears the infection.Continue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — A study of millions of people vaccinated against COVID-19 has identified those at greatest risk of hospitalization and death after breakthrough infection. The most vulnerable are those who are immunosuppressed from chemotherapy, a recent bone marrow or solid organ transplant, or HIV/AIDS. AlsoContinue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Hospitalized opioid addicts die at a rate similar to people who have a heart attack after leaving the hospital. Nearly 8% of patients addicted to opioids died within 12 months of hospital discharge, according to researchers from Oregon Health & Science University (OHSU).Continue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness. According toContinue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday. The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or aboveContinue Reading